Shiga toxin-induced thrombotic microangiopathy: A thrombin-dependent process?

Phillip Tarr

doi:10.1160/th04-05-0326

Shiga toxin-induced thrombotic microangiopathy: A thrombin-dependent process?

Phillip Tarr

Research output: Contribution to journal › Editorial

1 Scopus citations

Abstract

In summary, Raife et al. present quite provocative data. The potential use of a hirudin analogue to reverse the pathophysiologic cascade leading to HUS raises interesting questions. However, the best way to prevent HUS remains the prevention of primary human infection with E. coli O157:H7 and other STEC.

Original language	English
Pages (from-to)	227-228
Number of pages	2
Journal	Thrombosis and haemostasis
Volume	92
Issue number	2
DOIs	https://doi.org/10.1160/th04-05-0326
State	Published - Aug 2004

Access to Document

10.1160/th04-05-0326

Cite this

@article{21396fe812f640d49c4e95184339512b,

title = "Shiga toxin-induced thrombotic microangiopathy: A thrombin-dependent process?",

abstract = "In summary, Raife et al. present quite provocative data. The potential use of a hirudin analogue to reverse the pathophysiologic cascade leading to HUS raises interesting questions. However, the best way to prevent HUS remains the prevention of primary human infection with E. coli O157:H7 and other STEC.",

author = "Phillip Tarr",

year = "2004",

month = aug,

doi = "10.1160/th04-05-0326",

language = "English",

volume = "92",

pages = "227--228",

journal = "Thrombosis and haemostasis",

issn = "0340-6245",

number = "2",

}

TY - JOUR

T1 - Shiga toxin-induced thrombotic microangiopathy

T2 - A thrombin-dependent process?

AU - Tarr, Phillip

PY - 2004/8

Y1 - 2004/8

N2 - In summary, Raife et al. present quite provocative data. The potential use of a hirudin analogue to reverse the pathophysiologic cascade leading to HUS raises interesting questions. However, the best way to prevent HUS remains the prevention of primary human infection with E. coli O157:H7 and other STEC.

AB - In summary, Raife et al. present quite provocative data. The potential use of a hirudin analogue to reverse the pathophysiologic cascade leading to HUS raises interesting questions. However, the best way to prevent HUS remains the prevention of primary human infection with E. coli O157:H7 and other STEC.

UR - http://www.scopus.com/inward/record.url?scp=4444360024&partnerID=8YFLogxK

U2 - 10.1160/th04-05-0326

DO - 10.1160/th04-05-0326

M3 - Editorial

C2 - 15269815

AN - SCOPUS:4444360024

SN - 0340-6245

VL - 92

SP - 227

EP - 228

JO - Thrombosis and haemostasis

JF - Thrombosis and haemostasis

IS - 2

ER -

Shiga toxin-induced thrombotic microangiopathy: A thrombin-dependent process?

Abstract

Access to Document

Other files and links

Fingerprint

Cite this